PMID: 10342826

Ashfield R, Gribble FM, Ashcroft SJ, Ashcroft FM
Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Diabetes. 1999 Jun;48(6):1341-7., [PubMed]
Sentences
No. Mutations Sentence Comment
4 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:4:355
status: NEW
view ABCC8 p.Ser1237Tyr details
High-affinity tolbutamide inhibition could be conferred on SUR2A by replacing transmembrane domains (TMs) 14-16 with the corresponding region of SUR1. Conversely, high-affinity tolbutamide inhibition of SUR1 was abolished by replacing TMs 13-16 with the corresponding SUR2A sequence, or by mutating a single serine residue within this region to tyrosine (S1237Y). Login to comment
32 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:32:59
status: NEW
view ABCC8 p.Ser1237Tyr details
alent region of SUR2A or by a mutation within this region (S1237Y). Login to comment
127 ABCC8 p.Ser1201Cys
X
ABCC8 p.Ser1201Cys 10342826:127:110
status: NEW
view ABCC8 p.Ser1201Cys details
ABCC8 p.Leu1226Met
X
ABCC8 p.Leu1226Met 10342826:127:150
status: NEW
view ABCC8 p.Leu1226Met details
ABCC8 p.Ala1204Ser
X
ABCC8 p.Ala1204Ser 10342826:127:118
status: NEW
view ABCC8 p.Ala1204Ser details
ABCC8 p.Thr1130Ile
X
ABCC8 p.Thr1130Ile 10342826:127:78
status: NEW
view ABCC8 p.Thr1130Ile details
ABCC8 p.Cys1174Phe
X
ABCC8 p.Cys1174Phe 10342826:127:94
status: NEW
view ABCC8 p.Cys1174Phe details
ABCC8 p.Tyr1229Leu
X
ABCC8 p.Tyr1229Leu 10342826:127:142
status: NEW
view ABCC8 p.Tyr1229Leu details
ABCC8 p.Cys1128Thr
X
ABCC8 p.Cys1128Thr 10342826:127:70
status: NEW
view ABCC8 p.Cys1128Thr details
ABCC8 p.Gln1223Lys
X
ABCC8 p.Gln1223Lys 10342826:127:134
status: NEW
view ABCC8 p.Gln1223Lys details
ABCC8 p.Tyr1218His
X
ABCC8 p.Tyr1218His 10342826:127:126
status: NEW
view ABCC8 p.Tyr1218His details
ABCC8 p.Cys1141Ser
X
ABCC8 p.Cys1141Ser 10342826:127:86
status: NEW
view ABCC8 p.Cys1141Ser details
ABCC8 p.Gln1190Glu
X
ABCC8 p.Gln1190Glu 10342826:127:102
status: NEW
view ABCC8 p.Gln1190Glu details
Most mutations did not affect tolbutamide sensitivity: these included C1128T, T1130I, C1141S, C1174F, Q1190E, S1201C, A1204S, Y1218H, Q1223K, Y1229L, L1226M (data not shown; n = 2-4 patches in each case). Login to comment
138 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:138:66
status: NEW
view ABCC8 p.Ser1237Tyr details
While MgADP did not promote tolbutamide inhibition of Kir6.2-SUR1(S1237Y) currents, the nucleotide was able to enhance meglitinideblock(Fig. 4). Login to comment
145 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:145:101
status: NEW
view ABCC8 p.Ser1237Tyr details
The dashed lines indicate the data for Kir6.2-SUR1 and Kir6.2-SUR2A given in A and B. D: Kir6.2-SUR1(S1237Y) currents were fit with equation 4: Ki1 = 1.3 mmol/l, h1 = .9, L = 0 (n = 5). Login to comment
153 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:153:72
status: NEW
view ABCC8 p.Ser1237Tyr details
We comparedthe binding of [3 H]glibenclamide to SUR1, SUR12-e, and SUR1(S1237Y) expressed in Cos7 cells, and evaluatedprotein expression by immunoblotting with the M2 anti-FLAG antibody (Fig. 6). Login to comment
154 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:154:49
status: NEW
view ABCC8 p.Ser1237Tyr details
Binding of [3 H]glibenclamide to SUR12-e or SUR1(S1237Y) was not significantly greater than that found inuntransfected cells. Login to comment
158 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:158:172
status: NEW
view ABCC8 p.Ser1237Tyr details
High-affinity tolbutamide inhibition could be conferred on SUR2A by replacing TMs 14-16 with the equivalent region of SUR1. Conversely, the reverse chimera, or a mutation (S1237Y) within this region of SUR1, abolished both high-affinity tolbutamide block and [3 H]glibenclamide binding. Login to comment
169 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:169:162
status: NEW
view ABCC8 p.Ser1237Tyr details
Effects of tolbutamide (A) or meglitinide (B) in the presence or absence of 100 µmol/l MgADP, for channels comprising Kir6.2 and either SUR1, SUR2A, or SUR1(S1237Y). Login to comment
179 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:179:101
status: NEW
view ABCC8 p.Ser1237Tyr details
Oocytes were coinjected with mRNAs encoding Kir6.2 and either SUR1, SUR2A, SUR12-e, SUR21-x, or SUR1(S1237Y). Login to comment
194 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:194:41
status: NEW
view ABCC8 p.Ser1237Tyr details
This can be most simply explained if the S1237Y mutation specifically impaired tolbutamide binding, without interfering with either meglitinide binding or the mechanism by which sulfonylureas interfere with channel activation by MgADP. Login to comment
198 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:198:73
status: NEW
view ABCC8 p.Ser1237Tyr details
Thus, when SUR1 was rendered insensitive to tolbutamide [SUR12-e or SUR1(S1237Y)], glibenclamide block became reversible, while endowment of SUR2A with tolbutamide sensitivity (SUR21-x) was accompanied by irreversible glibenclamide inhibition. Login to comment
206 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:206:63
status: NEW
view ABCC8 p.Ser1237Tyr details
A: Membranes from Cos7 cells expressing SUR1, SUR12-e, or SUR1(S1237Y) were separated by SDS polyacrylamide gel electrophoresis, and probed with the anti-FLAG monoclonal antibody M2. Login to comment
208 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:208:99
status: NEW
view ABCC8 p.Ser1237Tyr details
B: [3 H]glibenclamide binding to membranes from Cos7 cells transfected with SUR1, SUR12-e, or SUR1(S1237Y) or to untransfected cells. Login to comment
220 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:220:56
status: NEW
view ABCC8 p.Ser1237Tyr details
In support of this view, we found that SUR12-e and SUR1(S1237Y), which form KATP channels that are blocked reversibly by glibenclamide, did not exhibit significant [3 H]glibenclamide binding. Login to comment
224 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 10342826:224:152
status: NEW
view ABCC8 p.Ser1237Tyr details
Conversely, high-affinity tolbutamide block and [3 H]glibenclamide binding were abolished by the reverse chimera or by mutation of a single amino acid, S1237Y, in the intracellular loop between TMs 15 and 16 of SUR1. Login to comment